✦ LIBER ✦

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial

✍ Scribed by Marc Decramer; Maureen Rutten-van Mölken; PN Richard Dekhuijzen; Thierry Troosters; Cees van Herwaarden; Riccardo Pellegrino; CP Onno van Schayck; Dario Olivieri; Mario Del Donno; Wilfried De Backer; Ida Lankhorst; Alfredo Ardia

Book ID: 117289414
Publisher: The Lancet
Year: 2005
Tongue: English
Weight: 115 KB
Volume: 365
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)66456-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of N-acetylcysteine on outcomes

Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): A randomised placebo-controlled trial: The Lancet 2005;365(9470):1552–60

✍ M. Decramer; M. Rutten-van Mölken; P.N.R. Dekhuijzen; T. Troosters; C. van Herwa 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Effect of tiotropium on outcomes in pati

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

✍ Marc Decramer; Bartolome Celli; Steven Kesten; Theodore Lystig; Sunil Mehra; Don 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 201 KB

Effects of Formoterol Inhaled Dry Powder

Effects of Formoterol Inhaled Dry Powder on Exercise Performance in Chronic Obstructive Pulmonary Disease: A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Crossover Study

✍ Leonello Fuso; Raffaele Antonelli Incalzi; Salvatore Basso; Salvatore Spadaro; L 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 91 KB

No Effect of the Calcium Antagonist, Isr

No Effect of the Calcium Antagonist, Isradipine, on Plasma Catecholamines in Irreversible Chronic Obstructive Pulmonary Disease (COPD). A Randomized, Double-blind, Placebo-controlled Study

✍ Niels A. Graudal; Anders M. Galløe; Inger Plum; Nils Milman; Jesper O. Clausen 📂 Article 📅 1995 🏛 Elsevier 🌐 English ⚖ 243 KB

SUMMARY: Calcium antagonists have been claimed to decrease the pulmonary artery pressure and increase oxygen uptake and cardiac output in patients with chronic obstructive pulmonary disease (COPD). This should tend to decrease the plasma levels of catecholamines. The purpose of the present study was

The effect of the calcium antagonist, is

The effect of the calcium antagonist, isradipine, on working capacity, pulmonary function, morbidity and survival rate in patients with severe chronic obstructive pulmonary disease (COPD): a randomized, double-blind, placebo-controlled study

✍ A. M. GALLØE; N. GRAUDAL; J. R. PETERSEN; P. LETH; M. GALLØE 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 474 KB